Cwc Advisors, Llc. Ligand Pharmaceuticals Inc Transaction History
Cwc Advisors, Llc.
- $176 Billion
- Q1 2025
A detailed history of Cwc Advisors, Llc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Cwc Advisors, Llc. holds 3,430 shares of LGND stock, worth $364,780. This represents 0.21% of its overall portfolio holdings.
Number of Shares
3,430
Previous 2,609
31.47%
Holding current value
$364,780
Previous $280 Million
29.0%
% of portfolio
0.21%
Previous 0.28%
Shares
3 transactions
Others Institutions Holding LGND
# of Institutions
278Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$305 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$222 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$108 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$94.1 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$79.1 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.8B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...